Actively Recruiting
Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2025-08-06
30
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to preliminarily evaluate the is to assess the effects and safety of electroacupuncture for moderate to severe dysmenorrhea secondary to adenomyosis.
CONDITIONS
Official Title
Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with dysmenorrhea secondary to adenomyosis.
- Female aged between 18 and 50 years.
- Dysmenorrhea lasting for at least 3 consecutive menstrual cycles.
- Menstrual cycles occurring every 24 to 38 days with less than 7 days difference between cycles and menstrual periods lasting 2 to 8 days prior to screening.
- Worst menstrual pain score of 4 or higher on a numerical rating scale for at least 2 days during screening.
- No use of medications or therapies for dysmenorrhea (other than rescue medicine) for at least 1 month before randomization and willing to avoid such treatments during the study.
- Willing to participate and able to provide written informed consent.
You will not qualify if you...
- Diagnosis of endometriosis or history of endometriosis-related surgery.
- Use of hormonal medications: GnRH agonists within 6 months, progestins/danazol/long-acting hormones within 3 months, or oral contraceptive-like short-acting hormones within 1 month before screening.
- Clinically significant gynecologic conditions such as significant endometrial pathology, ovarian cysts larger than specified sizes, or multiple/symptomatic fibroids.
- Presence of an intrauterine device (IUD).
- Hemoglobin level below 90 g/L.
- Any other chronic pain syndrome requiring chronic pain medication or therapy.
- Undiagnosed abnormal genital bleeding.
- Malignant tumors in reproductive or other systems.
- Severe diseases affecting cardiac, respiratory, renal, liver, hematopoietic systems, psychiatric or cognitive disorders.
- Pregnancy, breastfeeding, or planning pregnancy within the next 7 months.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, China
Actively Recruiting
Research Team
Z
Zhishun Liu
CONTACT
M
Min Yang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here